Most brokerages maintained a bullish view on Cipla citing the pharmaceutical major's healthy pipeline of product launches in the United States and growth in the domestic market. Shares of Cipla ended up at ₹932.15 on Friday.
from Economic Times https://bit.ly/3G4UdkM
from Economic Times https://bit.ly/3G4UdkM
Most brokerages bullish on Cipla; Cite US, local market growth potential
Reviewed by শ্রী শ্রী সত্যনারায়ণ নমঃ
on
January 29, 2022
Rating:
No comments: